Literature DB >> 19427267

A(2B) adenosine receptors in immunity and inflammation.

György Haskó1, Balázs Csóka, Zoltán H Németh, E Sylvester Vizi, Pál Pacher.   

Abstract

A(2B) adenosine receptors are increasingly recognized as important orchestrators of inflammation. A(2B) receptor activation promotes the inflammatory response of mast cells, epithelial cells, smooth muscle cells and fibroblasts, thereby contributing to the pathophysiology of asthma and colitis. A(2B) receptor stimulation limits endothelial cell inflammatory responses and permeability and suppresses macrophage activation thereby preventing tissue injury after episodes of hypoxia and ischemia. A(2B) receptor stimulation also promotes the production of angiogenic cytokines by endothelial cells, mast cells and dendritic cells, aiding granuloma tissue formation and inflammatory resolution, but can also contribute to tumor growth. A(2B) receptors are, thus, potentially important pharmacological targets in treating immune system dysfunction and inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19427267      PMCID: PMC2756472          DOI: 10.1016/j.it.2009.04.001

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  84 in total

Review 1.  Immunopathogenesis of inflammatory bowel disease: current concepts.

Authors:  Giorgos Bamias; Fabio Cominelli
Journal:  Curr Opin Gastroenterol       Date:  2007-07       Impact factor: 3.287

2.  A2A adenosine receptor protects tumors from antitumor T cells.

Authors:  Akio Ohta; Elieser Gorelik; Simon J Prasad; Franca Ronchese; Dmitriy Lukashev; Michael K K Wong; Xiaojun Huang; Sheila Caldwell; Kebin Liu; Patrick Smith; Jiang-Fan Chen; Edwin K Jackson; Sergey Apasov; Scott Abrams; Michail Sitkovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-17       Impact factor: 11.205

3.  IFN-gamma up-regulates the A2B adenosine receptor expression in macrophages: a mechanism of macrophage deactivation.

Authors:  J Xaus; M Mirabet; J Lloberas; C Soler; C Lluis; R Franco; A Celada
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

Review 4.  Shaping of monocyte and macrophage function by adenosine receptors.

Authors:  György Haskó; Pál Pacher; Edwin A Deitch; E Sylvester Vizi
Journal:  Pharmacol Ther       Date:  2006-09-14       Impact factor: 12.310

5.  Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation.

Authors:  Joseph Khoury; Juan C Ibla; Andrew S Neish; Sean P Colgan
Journal:  J Clin Invest       Date:  2007-02-22       Impact factor: 14.808

6.  HIF-dependent induction of adenosine A2B receptor in hypoxia.

Authors:  Tianqing Kong; Karen A Westerman; Marion Faigle; Holger K Eltzschig; Sean P Colgan
Journal:  FASEB J       Date:  2006-11       Impact factor: 5.191

Review 7.  Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade.

Authors:  Gennady G Yegutkin
Journal:  Biochim Biophys Acta       Date:  2008-02-12

8.  Enhanced mast cell activation in mice deficient in the A2b adenosine receptor.

Authors:  Xiaoyang Hua; Martina Kovarova; Kelly D Chason; MyTrang Nguyen; Beverly H Koller; Stephen L Tilley
Journal:  J Exp Med       Date:  2007-01-02       Impact factor: 14.307

9.  HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia.

Authors:  Holger K Eltzschig; Parween Abdulla; Edgar Hoffman; Kathryn E Hamilton; Dionne Daniels; Caroline Schönfeld; Michaela Löffler; German Reyes; Michael Duszenko; Jorn Karhausen; Andreas Robinson; Karen A Westerman; Imogen R Coe; Sean P Colgan
Journal:  J Exp Med       Date:  2005-12-05       Impact factor: 14.307

10.  From "Hellstrom Paradox" to anti-adenosinergic cancer immunotherapy.

Authors:  Dmitriy Lukashev; Michail Sitkovsky; Akio Ohta
Journal:  Purinergic Signal       Date:  2007-01-24       Impact factor: 3.765

View more
  97 in total

Review 1.  G protein-coupled receptors as therapeutic targets for multiple sclerosis.

Authors:  Changsheng Du; Xin Xie
Journal:  Cell Res       Date:  2012-06-05       Impact factor: 25.617

2.  Anti-inflammatory or proinflammatory effect of an adenosine receptor agonist on the Th17 autoimmune response is inflammatory environment-dependent.

Authors:  Dongchun Liang; Aijun Zuo; Hui Shao; Mingjiazi Chen; Henry J Kaplan; Deming Sun
Journal:  J Immunol       Date:  2014-11-03       Impact factor: 5.422

3.  A2b adenosine receptor regulates hyperlipidemia and atherosclerosis.

Authors:  Milka Koupenova; Hillary Johnston-Cox; Alexander Vezeridis; Haralambos Gavras; Dan Yang; Vassilis Zannis; Katya Ravid
Journal:  Circulation       Date:  2011-12-05       Impact factor: 29.690

4.  Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury.

Authors:  Ulrich Schingnitz; Katherine Hartmann; Christopher F Macmanus; Tobias Eckle; Stephanie Zug; Sean P Colgan; Holger K Eltzschig
Journal:  J Immunol       Date:  2010-03-26       Impact factor: 5.422

Review 5.  Extracellular adenosine: a safety signal that dampens hypoxia-induced inflammation during ischemia.

Authors:  Almut Grenz; Dirk Homann; Holger K Eltzschig
Journal:  Antioxid Redox Signal       Date:  2011-04-11       Impact factor: 8.401

6.  A(₂B)AR expression in non-immune cells plays an important role in the development of murine colitis.

Authors:  Sarah A Ingersoll; Hamed Laroui; Vasantha L Kolachala; Lixin Wang; Pallavi Garg; Timothy L Denning; Andrew T Gewirtz; Didier Merlin; Shanthi V Sitaraman
Journal:  Dig Liver Dis       Date:  2012-06-19       Impact factor: 4.088

Review 7.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

Review 8.  The role of adenosine signaling in sickle cell therapeutics.

Authors:  Joshua J Field; David G Nathan; Joel Linden
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

9.  Characterization of Dahl salt-sensitive rats with genetic disruption of the A2B adenosine receptor gene: implications for A2B adenosine receptor signaling during hypertension.

Authors:  Shraddha Nayak; Md Abdul H Khan; Tina C Wan; Hong Pei; Joel Linden; Melinda R Dwinell; Aron M Geurts; John D Imig; John A Auchampach
Journal:  Purinergic Signal       Date:  2015-09-18       Impact factor: 3.765

10.  Role of the A(2B) receptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats.

Authors:  L Antonioli; M Fornai; O Awwad; G Giustarini; C Pellegrini; M Tuccori; V Caputi; M Qesari; I Castagliuolo; P Brun; M C Giron; C Scarpignato; C Blandizzi; R Colucci
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.